Introduction
Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of individuals at high risk for sudden cardiac death (SCD). After the publication of landmark randomized trials performed in select patient populations, practice guidelines recommend the consideration of ICDs for the primary prevention of SCD in a large number of patients with left ventricular systolic dysfunction. [1] [2] [3] [4] [5] ICDs are thus now frequently used in this population.
Because practice guidelines and coverage decisions substantially expanded the population eligible for primary prevention ICD therapy, in some cases with concomitant cardiac resynchronization therapy (CRT-D), the patterns of use and outcomes of this therapy in community practice settings have been an important focus of research. An evolving understanding of patient populations that benefit the most from therapy, revisions of practice guidelines, 4-5 the evolution of ICD technology over time, and increasing experience of implanting clinicians 6 could all influence patterns of patient selection for ICD therapy and the outcomes among the patients who receive ICDs. While recent data suggests improvements in hospital care for patients receiving ICD therapy, little is known about the temporal trends in patient characteristics and longer-term outcomes among those with primary prevention ICD implantation. m mp pl planting cli ini ni ic ci c a an ans s 6 6 6 cou ou ould ld ld a al ll ll i inf nf nflu lu uen en nc ce e pa a atte erns s o o of p pat at atie ien nt nt s s sel ele e ect ti ion on f f for r r I ICD CD CD t the he era ra r py py p and nd nd t the he he ou utc tc tcom om omes es a a amo mo m ng ng g t the he h p p pat at tie ient nts s s wh wh who o o re r rece ce eiv iv ve e e IC IC ICDs Ds Ds. . Wh Wh W il l le e re re rec ce cent nt nt d da a ata a a su su s g g gge es ests ts s i imp mp mpro ro ov v vem m men nt nts s i in in hospital care e fo fo for r r pa pa pati ti tien en nt t ts s re e ece ce ceiv ivin in ing g g IC IC ICD D D th th her er rap ap apy, y, y, l l lit it ttl tl le e e is s s k k kno no now w wn n n ab ab a ou ou out t t th th the e e te te temp mp por or oral al al t tre re r nds in
Methods

Data Source
Data was obtained from the NCDR ICD Registry; the details of which have been reported previously. 8 The ICD Registry was established after the Centers for Medicare & Medicaid Services (CMS) announced their expanded coverage for primary prevention ICD implantation. In addition to expanded coverage, CMS mandated that data on all Medicare primary prevention implants be entered into a national ICD registry. 8 The registry collects data from over 1,500 hospitals in the United States and includes more than 850,068 ICD procedures as of the end of 2011. 9, 10 CMS mandates the entry of data for all primary prevention ICD implantations in Medicare beneficiaries as a condition of payment. 9 The registry uses both a standardized data set and definitions, has requirements in place to ensure uniform data entry and transmission, and is subject to data quality checks. 11 All data submissions are evaluated for errors and completeness. This information is summarized in an automated report that is sent to the participants after each data submission. The NCDR audit program, which includes hospital chart reviews and blinded data abstractions, serves as an additional mechanism to assess the accuracy of the data and enables participants to identify areas for improved data entry.
Use of the NCDR was approved by the ICD Registry Research and Publication
Committee. Statistical analysis was approved and completed by the Yale Center for Outcomes
Research and Evaluation. The analysis was approved by the Yale University Human Investigation Committee.
Study Population
Medicare beneficiaries aged 65 years or older in the NCDR were included. This population was all primary prevention ICD implantations in Medicare beneficiaries as a conditio on n n of of o p p pay ay ayme me ment nt. 9 The registry uses both a standardized data set and definitions, has requirements in place to ensure un nif if for or orm m m da da data ta ta ent ntry ry ry a and transmission, and is subj jec ec e t t to data quality y y chec ec ck ks ks. 11 All data submissions ar re ev e aluated fo for r r e e erro ror r rs a a and nd nd c c co om ompl pl let et ten en nes ss. T T Th hi is in nf nfo o orm ma mat ti tion on n i i is s su su um mm mmar ar riz zed ed i i in n n an an a a aut ut utom om mat at at d ed ed e epo po port rt rt t t tha hat t is is is s sen ent t t to to t th h he p p pa artic ic icip ip pan an ants ts ts a af ft fter er r e e eac a ach h h da da dat ta ta s su ub ubmi mi mis ss ssio o on. n. n T The he he N N NCD CD DR R R au au udi dit t t pr pr prog og gra a am, m, which includ des es es h h hos os ospi pi pita ta al l l ch h har ar art t t re e evi vi view ew ws s an an and d 12 Patients meeting eligibility criteria who could be linked to Medicare data formed the principal analytic cohort of the study. Hospital characteristics and implanting operator training were ascertained from the NCDR data form.
Outcomes
Outcomes of interest included all-cause mortality at 180 days, re-hospitalization (for all-causes and heart failure) at 180 days, and device related complications according to the modified CMS definitions (pneumothorax or hemothorax at 30 days, hematoma requiring transfusion or surgical evacuation at 30 days, pericardial tamponade requiring pericardiocentesis at 30 days, mechanical complications with system revisions [lead revision] at 90 days, device-related infection at 90 days, ICD replacement at 90 days, death at 30 days). 13 Baseline patient characteristics were ascertained from the ICD Registry while outcomes were ascertained from Medicare claims.
Statistical Analysis
To compare the groups of patients for whom Medicare matching was possible with those who could not be matched, we calculated standardized differences in percentage points. Standardized differences less than 10% are considered to represent balance between groups.
For each of the patient characteristics, we evaluated changes (differences) over the study years across the study period using the chi square test for categorical variables and F-test in
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Results
Study Population
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Patient Demographics
The temporal trends in patient characteristics stratified by year are presented in Table 1 .
Because of the sample size, many of the differences were statistically significant. The mean age for the entire group was 75.1 ± 6.2 years. Between 2006 and 2010, the proportion of patients' age 75 or less increased from 47.4% to 48.5% and those at least 85 years old increased from 6.5% to 7.6% (p<0.001). The proportion of women undergoing ICD implantation increased modestly (27.3% to 28.4%, p= 0.001). Implantation rates of white non-Hispanic patients decreased from 86.0% to 84.5%, while rates increased among black and Hispanics, 7.7% to 8.8%, and Hispanics, 4.1% to 4.7%, (p<0.001).
Cardiovascular characteristics
Between 2006 and 2010, cardiovascular comorbidities were largely stable although the observed small differences were statistically significant in several instances due to the large numbers of study subjects. The changes of greatest absolute magnitude included the proportion of patients with NYHA Class IV symptoms, which decreased from 5.6% to 3.8%, while patients with NYHA Class III symptoms increased from 56.1% to 60.4% (p<0.001). The proportion of patients with non-ischemic cardiomyopathy increased from 28.0% to 32.0% (p<0.001). The
Because of the sample size, many of the differences were statistically significan nt. t. . T The he h m m mea ea ean n n ag age for the entire group was 75. 
Implanting Operator Training and Hospital Characteristics
The implanting operator training and hospital characteristics over time are shown in Table 2 .
The majority of implants were performed by board-certified electrophysiologists, which increased over time (40.2% in 2006 and 64.0% in 2010, p<0.001). Modest changes in hospital characteristics were observed across the study years, with the majority of hospitals being urban, private/ community institutions.
Outcomes
The temporal trends in outcomes are presented in Table 3 . All adverse outcomes improved over time. Six-month mortality significantly declined over the study years ( The implanting operator training and hospital characteristics over time are shown in Table 2 .
Th he e e ma ma maj jo jori ri rity ty ty of f im im impl p ants were performed by boa a ard rd r --certified electr tr rophy hy ysi si siol o ogists, which n ncr r rea e sed over r t tim im ime ( Existing studies describing the temporal trends in patient characteristics undergoing ICD implantation have been limited to few centers, included secondary prevention ICD implants, or not been able to assess trends over long time periods. 14-15 A study in Olmsted County found that patients undergoing ICD implantation were older and more likely male over time. 14 However, this data was derived from a single center, tertiary referral hospital with data collection ending in 2004. A previous study from ICD registry identified improvements in in-hospital major and minor complications during a similar study period. 7 However, this study did not characterize longer-term outcomes after hospitalization including complications that occurred after hospital discharge. The current study demonstrates the value of the ICD registry in generating data to characterize trends in ICD implantation across the US in contemporary practice.
Observed characteristics of patients undergoing ICD implantation changed little from 2006 to 2010, indicating that there does not appear to be greater permissiveness in the use of primary prevention ICDs. Expanding the use of therapies in broader populations is not necessarily associated with better outcomes (e.g. erythropoietin stimulating agents for heart failure or carotid artery revascularization with stenting in certain patient subsets 16, 17 ). The increasing use of primary prevention ICD implants has not been associated with a substantial trend in use in patients with a greater burden of coexisting illness or poorer prognosis.
Alternatively, there appears to be a reassuring consistent approach to patient selection for ICD his data was derived from a single center, tertiary referral hospital with data col lle le ect ct tio ion n n en en endi di ding ng n in a 2004. A previous study from ICD registry identified improvements in in-hospital major and mi mino no nor r r c co comp mp mpli li licati ti ion on ons s during a similar study perio o od d. d 7 7 7 However, this is s stu udy dy dy d did not characterize o ong g ger e -term ou utc tc com m mes es aft ft fter er er h h ho os ospi pita ta tal li liza za ati io on i inc nc clud di in ng c com om mp pl plic c cat ati io on n ns th th ha a at o occ cc cur ur rre red d d af af fte te t r r ho ho osp spit i i a a al di disc sc scha ha harg rg rge. e. Th Th The e c cu curr rr r en en nt st st s ud u y y y de de demo mo mon ns nstr tr rat at tes es es t t the e e v va a alu ue ue o o of f th th the e e IC C CD D D re re egi gi gist str ry ry i in n ge ge g ne ne n ra ra ati ti ting ng da at ata a t t to characterize t tre re rend nd nds s s in in i I I ICD CD C i i imp mp m la la ant nt n at at atio i n n n ac ac acr r ros os oss s s th th the e US US U i in n n co co cont n n em em empo po pora ra r ry ry ry p p pra ra ract ct c ic c ce. e. e.
therapy. This study did not assess the appropriateness of primary prevention ICD implantation, however a previous examination of the ICD registry over a similar study period demonstrated no clear changes in rates of use of ICDs according to CMS reimbursement criteria, which are related to guideline-recommendations for ICD use.
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Women and racial minorities made up a relatively small proportion of patients receiving primary prevention ICD therapy in the Medicare population. Although we are not able to determine the clinical justification for this observation, previous studies have demonstrated that both gender and racial disparities exist with regard to use of ICD therapy. [19] [20] [21] [22] [23] [24] [25] However, a previous study from the ICD registry found that women were no more likely than men to meet guideline criteria for primary prevention ICD implantation, suggesting that gender differences
are not related to a disproportionate overutilization among men. 26 The extent to which these trends exist are unclear indicating the need for a better understanding of the reasons for these differences.
The six-month mortality among all patients significantly declined over the study years.
Additionally, the mortality rates are low at six months as compared with previous observations. 27-29 A prior study found that patients from the ICD Registry had identical survival rates as similar patients enrolled in the randomized trials that established the efficacy of primary prevention ICDs. 30 Indeed, the patient population in this study varied greatly as compared to those included in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) and the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) with the mean age being 60 and 64 years old, respectively, and the rates of diabetes, atrial fibrillation/flutter, and severity of heart failure all being higher in the NCDR registry patients. 1, 3 This adds important data to the existing knowledge that despite an aging population, the outcomes of patients undergoing guideline criteria for primary prevention ICD implantation, suggesting that gende de er di di d ff ff ffer er eren en ence ce c s s
are not related to a disproportionate overutilization among men. 26 The extent to which these r ren en nds ds ds e e exi xi xist st st a ar re u u unc nc ncle l ar indicating the need fo r r a a a be be b t tter understan ndi di d ng g o o of f f t the reasons for these d di diff f fer e ences.
Th The e e si si six-x-mo mo mont nth h h m mo mort r al al alit ity y y am am amon ong g g al al all l l p pa pati ti tien en ent t ts s sig gn gnif if ific ic ican an ntl tl tly y de de ecl cl c in in ned d d o ov ve ver r r th the e e s st stud d dy ye ye y ar a ars s. .
Additionally y y, , th th the e mo mo mort rt tal al lity y y ra ra rate t t s s s ar ar a e e e lo l w w w at at at si si s x x x mo mo mont nt nths hs h a a as s s co co comp mp mpar ar ared d d w w wit it ith h h pr pr prev ev e io io ious us us primary prevention ICD implantation has continued to improve. Notably, there was heterogeneity in outcomes among patients according to device type including higher mortality over time among those receiving single chamber ICDs. The reasons for this trend are unclear, and warrant further scrutiny over time. One plausible explanation for this trend may be selection bias, whereby clinicians take into consideration factors such as frailty, which we were unable to measure, leading to selection of single chamber ICDs among patients who are deemed higher risk.
Improvements were observed in re-hospitalization rates, which were driven largely by lower rates of heart failure re-hospitalization. Although not specifically among patients receiving primary prevention ICDs, similar observations in populations of patients with heart failure population have demonstrated improvements. [31] [32] [33] [34] The reasons for this trend are unclear; it is plausible that with greater focus on readmission in patients with heart failure that improvements in care transitions have occurred. This study did not examine changes in medical therapy across the study years, however improvements in prescription of optimal medical therapy, including beta-blockers and ACE inhibitor/angiotensin receptor blockers, has been shown in a similar cohort of patients undergoing ICD implantation in the ICD Registry and may account for lower rates of re-hospitalization. 7 Additionally, as use of cardiac resynchronization therapy has been shown to reduce the rate of heart failure hospitalization by 37%, the increase in use of CRT-D devices observed in the present study may contributed to this improvement. 35 However, the temporal decline in hospitalization rates persisted after adjustment for device type, suggesting other contributors to the trend. Certain factors should be considered in the interpretation of this study. First, our analysis was confined to Medicare patients. Thus our results may not apply to the broader population of patients undergoing primary prevention ICD implantation. However, the older patient population historically has the highest event rates among patients, consequently the present data may overestimate the adverse outcomes in younger patients undergoing ICD implantation.
Second, our analysis was limited to the patients for which we could match Medicare claims information. However, the matched cohort was largely similar to the unmatched cohort in terms of measured characteristics. Thirdly, our outcomes were restricted to six-months after ICD implantation; an analysis of longer-term outcomes including mortality and re-hospitalization would complement this study. Finally, we cannot exclude the possibility that unmeasured confounding may account for some of the observed trends in outcomes.
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